Enzymatically triggered glucose-releasing scaffolds as nutritional supports for millimeter-scale tissue engineering.
Laowpanitchakorn P., Piantino M., Matsuo T., Matsusaki M.
Laboratory Study on Hip, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Mater Today Bio (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42540439
- DOI
- 10.1016/j.mtbio.2026.103474
Abstract (original English)
Construction of millimeter-sized tissues to mimic real human tissue or organ is still challenging, as oxygen and nutrients have a diffusion limit of only 100-200 μm from blood vessels. Almost all mammalian cells except red blood cells and platelets need a glucose supply to support their metabolic activities and functions. Inspired by the properties of blood vessels, we developed an alginate scaffold that is capable to release glucose by hydrolysis of glycogen via enzymes such as amyloglucosidase in this study. The scaffold can be flexibly shaped into glucose-releasing capsules (Glc-RCs) and glucose-releasing fibers (Glc-RFs). It was demonstrated that Glc-RCs can provide sustained release of glucose for up to 4 days and have no negative effect on C2C12 mouse myoblast cell and human adipose-derived mesenchymal stem cell proliferation. Glc-RCs could also support differentiation of C2C12 into myotubes after 7 days of application without the need for media replenishment. Glc-RFs were incorporated into millimeter-scale 3D tissue-engineered constructs, where they reduced the apoptotic activity of normal human dermal fibroblasts (NHDFs) located within approximately 1000 μm from the fibers. In particular, the relationship between glucose diffusion distance and resulting cellular responses like apoptosis has not previously been documented in other glucose-releasing material studies. Thus
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level ASystematic ReviewEurope PMC
The Role of Exosome-miRNA as Biomarkers of Alzheimer's Disease: A Systematic Review of Case-Control and Longitudinal Studies
Systematic Review with a reported sample of 3046 on Neuroinflammation, published in Actas Esp Psiquiatr (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3046
Actas Esp Psiquiatr - Level AMeta-analysisEurope PMC
Exosome-based therapy for epilepsy: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Neuroinflammation, published in Front Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurosci - Level AMeta-analysisEurope PMC
Efficacy of stem cell therapy for achilles tendon rupture: a systematic review and meta-analysis based on animal studies
Meta-analysis on Tendon Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol